Transcend Capital Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Transcend Capital Advisors’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.06M	Sell	14,022 -1,976	-12%	-$305K	0.16%	124
2025 Q4	$2.48M	Sell	15,998 -21,806	-58%	-$3.27M	0.19%	108
2025 Q3	$5.26M	Sell	37,804 -12,252	-24%	-$1.66M	0.37%	52
2025 Q2	$6.75M	Sell	50,056 -1,443	-3%	-$195K	0.52%	40
2025 Q1	$7.52M	Sell	51,499 -1,473	-3%	-$214K	0.54%	40
2024 Q4	$7.29M	Buy	52,972 +391	+0.7%	+$57.2K	0.53%	42
2024 Q3	$8.1M	Sell	52,581 -5,400	-9%	-$819K	0.54%	39
2024 Q2	$8.45M	Sell	57,981 -14,949	-20%	-$2.14M	0.61%	31
2024 Q1	$10.8M	Buy	72,930 +5,706	+8%	+$819K	0.86%	20
2023 Q4	$9.17M	Buy	67,224 +2,793	+4%	+$363K	0.81%	23
2023 Q3	$8.29M	Sell	64,431 -11,583	-15%	-$1.54M	0.81%	24
2023 Q2	$10.1M	Buy	76,014 +4,783	+7%	+$631K	0.96%	15
2023 Q1	$9.22M	Sell	71,231 -6,606	-8%	-$863K	0.96%	17
2022 Q4	$10.6M	Buy	77,837 +165	+0.2%	+$21.9K	1.15%	10
2022 Q3	$9.41M	Buy	77,672 +8,020	+12%	+$1.03M	1.04%	13
2022 Q2	$8.93M	Buy	69,652 +5,446	+8%	+$714K	0.93%	19
2022 Q1	$8.8M	Buy	64,206 +9,454	+17%	+$1.25M	0.79%	22
2021 Q4	$7.71M	Buy	54,752 +1,099	+2%	+$146K	0.68%	26
2021 Q3	$7.11M	Buy	+53,653	New	+$7.09M	0.64%	29
2021 Q2	–	Sell	-52,898	Closed	-$6.18M	–	444
2021 Q1	$6.18M	Buy	52,898 +4,701	+10%	+$543K	0.74%	21
2020 Q4	$5.47M	Buy	48,197 +13,599	+39%	+$1.48M	0.72%	21
2020 Q3	$3.65M	Sell	34,598 -1,205	-3%	-$127K	0.66%	33
2020 Q2	$3.58M	Sell	35,803 -4,247	-11%	-$419K	1.17%	21
2020 Q1	$3.55M	Buy	40,050 +5,942	+17%	+$577K	1.06%	20
2019 Q4	$3.47M	Buy	+34,108	New	+$3.28M	0.94%	24

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

Transcend Capital Advisors's XLV Position: Q1 2026 in Review

Transcend Capital Advisors reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 12% in Q1 2026, selling an estimated $305K and leaving 14,022 shares worth $2.06M. The position accounts for 0.16% of the portfolio, ranked #124.

Transcend Capital Advisors first reported a position in XLV in Q4 2019 and has held it in 25 quarters since. The position peaked at $10.8M in Q1 2024. 1,804 funds tracked by Wall St. Rank hold XLV as of Q1 2026.

Transcend Capital Advisors held 14,022 shares of State Street Health Care Select Sector SPDR ETF worth $2.06M as of Q1 2026.
Transcend Capital Advisors sold 1,976 State Street Health Care Select Sector SPDR ETF shares in Q1 2026, an estimated $305K.
State Street Health Care Select Sector SPDR ETF made up 0.16% of Transcend Capital Advisors's portfolio in Q1 2026, its #124 holding.
Transcend Capital Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2019 and has held it in 25 quarters since.
Transcend Capital Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $10.8M in Q1 2024.
1,804 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.